Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.

Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, Mosier S, Lin MT, Eberhart CG, Burger PC.

Acta Neuropathol. 2012 Nov;124(5):627-41. doi: 10.1007/s00401-012-1037-x. Epub 2012 Sep 1.

PMID:
22941225
2.

Diffuse leptomeningeal neuroepithelial tumor: 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry.

Schniederjan MJ, Alghamdi S, Castellano-Sanchez A, Mazewski C, Brahma B, Brat DJ, Brathwaite CD, Janss AJ.

Am J Surg Pathol. 2013 May;37(5):763-71. doi: 10.1097/PAS.0b013e31827bf4cc.

PMID:
23588371
3.

Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component.

Takeuchi H, Kubota T, Kitai R, Matsuda K, Hashimoto N, Sato K.

J Neurooncol. 2009 Jan;91(1):33-8. doi: 10.1007/s11060-008-9690-6. Epub 2008 Sep 10.

PMID:
18781279
4.

Anaplastic oligodendroglioma with ganglioglioma-like maturation.

Tanaka Y, Nobusawa S, Yagi S, Ikota H, Yokoo H, Nakazato Y.

Brain Tumor Pathol. 2012 Oct;29(4):221-8. doi: 10.1007/s10014-011-0078-5. Epub 2012 Jan 11.

PMID:
22231405
5.

Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide.

Michotte A, Chaskis C, Sadones J, Veld PI, Neyns B.

J Neurol Sci. 2009 Dec 15;287(1-2):267-70. doi: 10.1016/j.jns.2009.08.047. Epub 2009 Sep 13.

PMID:
19751941
7.

Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases.

Jentoft M, Giannini C, Rossi S, Mota R, Jenkins RB, Rodriguez FJ.

Am J Surg Pathol. 2011 Jun;35(6):845-52. doi: 10.1097/PAS.0b013e3182189693.

PMID:
21552114
8.

Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. Case report.

Bourne TD, Mandell JW, Matsumoto JA, Jane JA Jr, Lopes MB.

J Neurosurg. 2006 Dec;105(6 Suppl):465-9.

PMID:
17184079
9.

Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?

Ramirez C, Bowman C, Maurage CA, Dubois F, Blond S, Porchet N, Escande F.

Neuro Oncol. 2010 May;12(5):490-9. doi: 10.1093/neuonc/nop071. Epub 2010 Feb 14.

10.

Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients.

Rodriguez FJ, Tihan T, Lin D, McDonald W, Nigro J, Feuerstein B, Jackson S, Cohen K, Burger PC.

Am J Surg Pathol. 2014 Aug;38(8):1058-70. doi: 10.1097/PAS.0000000000000221.

11.

Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.

Roldán G, Scott J, George D, Parney I, Easaw J, Cairncross G, Forsyth P, Yan E.

Can J Neurol Sci. 2008 May;35(2):204-9.

PMID:
18574935
12.

Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child.

Rossi S, Rodriguez FJ, Mota RA, Dei Tos AP, Di Paola F, Bendini M, Agostini S, Longatti P, Jenkins RB, Giannini C.

Acta Neuropathol. 2009 Oct;118(4):575-7. doi: 10.1007/s00401-009-0565-5. Epub 2009 Jun 27. No abstract available.

PMID:
19562354
13.

Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.

Rodriguez FJ, Scheithauer BW, Jenkins R, Burger PC, Rudzinskiy P, Vlodavsky E, Schooley A, Landolfi J.

Am J Surg Pathol. 2007 Mar;31(3):351-62.

PMID:
17325476
14.

Prognosis of oligodendroglial tumor with ring enhancement showing central necrotic portion.

Choi KY, Jung TY, Jung S, Kim YH, Moon KS, Kim IY, Kang SS, Lee KH.

J Neurooncol. 2011 May;103(1):103-10. doi: 10.1007/s11060-010-0353-z. Epub 2010 Aug 25.

PMID:
20737192
15.

Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.

Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G.

Brain Pathol. 2004 Apr;14(2):121-30.

PMID:
15193024
16.

Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?

Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A; German Glioma Network.

Clin Cancer Res. 2007 Dec 1;13(23):6933-7.

17.

Spinal cord glioneuronal tumor with neuropil-like islands with 1p/19q deletion in an adult with low-grade cerebral oligodendroglioma.

Fraum TJ, Barak S, Pack S, Lonser RR, Fine HA, Quezado M, Iwamoto FM.

J Neurooncol. 2012 Apr;107(2):421-6. doi: 10.1007/s11060-011-0760-9. Epub 2011 Nov 15.

PMID:
22083647
18.

Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.

Kreiger PA, Okada Y, Simon S, Rorke LB, Louis DN, Golden JA.

Acta Neuropathol. 2005 Apr;109(4):387-92. Epub 2005 Mar 1.

PMID:
15739101
19.

[Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors].

Absaliamova OV, Korshunov AG, Loshakov VA, Kobiakov GL, Golanov AV, Urakov SV, Amanov RD, Lichinitser MR.

Zh Vopr Neirokhir Im N N Burdenko. 2009 Jan-Mar;(1):17-23; discussion 23-4. Russian.

PMID:
19507310
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk